Parkinson’s Institute

Biogen, Parkinson’s Institute and Clinical Center partner

Monday, July 27, 2015

Biogen and the Parkinson’s Institute and Clinical Center, based in Sunnyvale, Calif., have formed a strategic alliance focused on enhancing the understanding of the underlying biology of Parkinson’s disease (PD) and the creation of novel tools and programs that could accelerate R&D of new PD treatments. The agreement will combine the clinical experience and data of the Institute with Biogen’s focus on neurodegenerative disease and approach to clinical development.

[Read More]

Berg, the Parkinson’s Institute partner for clinical development

Friday, February 21, 2014

Berg and the Parkinson’s Institute and Clinical Center have announced the next phase in their ongoing partnership, focused on identifying potential biomarkers that may lead to breakthroughs in the research, diagnosis, and treatment of Parkinson’s disease. Using Berg’s Interrogative Biology platform to analyze multi-omic tissue samples (skin fibroblasts, blood, urine) supplied by the Parkinson’s Institute, this collaboration will identify the differences between healthy and diseased tissues in an effort to unravel the mysteries of Parkinson’s disease. Berg and the Parkinson’s Institute together are the first teams to approach biomarker discovery by looking at proteomics, metabolomics, and lipidomics, in addition to clinical data, simultaneously in human patients and controls from the same cohort.   

[Read More]